CNC Stock News & Analysis | Latest Updates

CNC Investors Have Opportunity to Lead Centene Corporation Securities Fraud Lawsuit

NEW YORK, Aug. 6, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Centene Corporation (NYSE: CNC) between December 12, 2024 and June 30, 2025, both dates inclusive (the "Class Period"), of the important September 8, 2025...

August 6, 2025Lawsuits

CNC News

CNC Investors Have Opportunity to Lead Centene Corporation Securities Fraud Lawsuit

$1000 Invested In Centene 15 Years Ago Would Be Worth This Much Today

Morgan Stanley Initiates Coverage On Centene with Overweight Rating, Announces Price Target of $70

Breaking Down Centene: 5 Analysts Share Their Views

Barclays Downgrades Centene to Equal-Weight, Lowers Price Target to $65

If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today

Elizabeth Warren Says Jeff Bezos And Elon Musk 'Are Popping Champagne' As House Passes Trump's 'Big, Beautiful Bill' She Calls A Handout To Billionaires

If You Invested $1000 In This Stock 20 Years Ago, You Would Have This Much Today

How Do Investors Really Feel About Centene?

Reported Friday, Arizona Complete Health Secures Six-Year Contract To Lead Arizona Long Term Care Medicaid Services

Jefferies Maintains Hold on Centene, Lowers Price Target to $61

Guggenheim Reiterates Neutral on Centeneto Neutral

Forecasting The Future: 4 Analyst Projections For Centene

Barclays Maintains Overweight on Centene, Lowers Price Target to $84

Here's How Much You Would Have Made Owning Centene Stock In The Last 20 Years

Insurer Centene Reaffirms Annual Profit Guidance, Reports Better Than Expected Q1 Earnings

UPDATE: Centene Expects FY25 Adj. EPS Of More Than $7.25 Vs $7.23 Estimate

UPDATE: Centene Expects GAAP FY2025 EPS Of More Than $6.19 Vs $6.23 Estimate

Centene FY2025 expected to be more than $7.25 vs $7.23 Est

Centene FY2025 expected to be more than $6.19 vs $6.23 Est

Centene Q1 Adj. EPS $2.90 Beats $2.54 Estimate, Sales $46.62B Beat $43.36B Estimate

Centene's Earnings: A Preview

Here's How Much $1000 Invested In Centene 20 Years Ago Would Be Worth Today

Baird Maintains Neutral on Centene, Lowers Price Target to $69

Guggenheim Initiates Coverage On Centene with Neutral Rating

This Centene Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday

Jefferies Upgrades Centene to Hold, Raises Price Target to $64

Here's How Much You Would Have Made Owning Centene Stock In The Last 20 Years

Peering Into Centene's Recent Short Interest

Centene Subsidiary, Meridian Health Plan of Illinois, To Continue Providing Medicare And Medicaid Services For Dually Eligible Members In Illinois

Centene Expects To Reaffirm Its Previously Issued 2025 Adjusted EPS Guidance Of Greater Than $7.25 (Est $7.23) - Filing

Here's How Much You Would Have Made Owning Centene Stock In The Last 20 Years

Superior HealthPlan, A Company Of Centene To Provide $200,000 Through Annual Grant Program

Centene Plans To Reaffirm 2025 Full Year Adjusted EPS Guidance Floor Of Greater Than $7.25, Est $7.23

If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today

A Glimpse Into The Expert Outlook On Centene Through 9 Analysts

Wells Fargo Maintains Overweight on Centene, Lowers Price Target to $72

(CNC) - Analyzing Centene's Short Interest

Here's How Much You Would Have Made Owning Centene Stock In The Last 15 Years

Looking Into Centene's Recent Short Interest

(CNC) - Analyzing Centene's Short Interest

Wells Fargo Maintains Overweight on Centene, Lowers Price Target to $90

Centene's Buckeye Health Plan Awarded Contract To Serve Dual Eligible Medicare And Medicaid Members In Ohio

General Motors And 3 Other Stocks Insiders Are Selling